Displaying 181 - 200 of 210 results

Scleroderma Genomics and Health Disparities Unit Tables

https://www.niams.nih.gov/labs/scleroderma-genomics-and-health-disparities-lap/tables

« Scleroderma Genomics and Health Disparities Unit Table 1. Clinical Manifestations of scleroderma patients in the GRASP cohort (Morgan, Gourh, et al, Medicine 2017) Diffuse Scleroderma Telangiectasia Calcinosis Pulmonary ∥† Fibrosis FVC% pred † ≤70 Pulmonary ¶† Hypertension Scleroderma Renal Crisis Age at onset 0.99 (0.97-1.00) 0.99 (0.98-1.01) 1.00 (0.98-1.01)

Psoriasis

https://www.niams.nih.gov/health-topics/psoriasis

La psoriasis es una enfermedad de la piel que provoca que ciertas áreas de esta se enrojezcan y se vuelvan escamosas, pudiendo estar adoloridas, hinchadas o calientes. Aprenda más sobre los diferentes tipos de psoriasis y sus causas.

Subset Analysis in Clinical Studies Roundtable - March 11, 2020

https://www.niams.nih.gov/about/meetings-events/roundtables/subset-analysis-clinical-studies-roundtable-march-11-2020

See participant list See Backgrounder Summary Welcome (Bob Carter, 0:00 1) Dr. Carter provided an overview of why NIAMS was holding this meeting (see background), acknowledged key staff who were involved in its development, and urged participants to keep the discussions focused on the scientific needs and opportunities related to subset analysis in clinical studies. He asked everyone to think broadly about how the various statistical approaches could be applied to NIAMS mission areas and to share their contributions during the afternoon discussion. 1 Times are noted in approximate hours and minutes on the videocast. The link does not take

Cartilage Preservation and Restoration in Knee Osteoarthritis: Challenges, Gaps, and Opportunities Roundtable - September 2022

https://www.niams.nih.gov/about/meetings-events/roundtables/cartilage-preservation-and-restoration-knee-osteoarthritis

NIAMS organized a roundtable to engage stakeholders to discuss challenges, gaps, and opportunities regarding regenerative medicine approaches for cartilage preservation and restoration in knee OA and where and how NIAMS could play a role and move the field forward.

NIAMS Clinical Trial Working Group: Recommendations to Advisory Council

https://www.niams.nih.gov/about/working-groups-and-committees/advisory-council/niams-clinical-trial-working-group

Overview The NIAMS Clinical Trial Working Group was established to consider how the institute could optimally solicit and fund applications for clinical trials that would have the greatest impact in improving clinical outcomes, whether of rare or common diseases, for people with diseases and/or conditions within the NIAMS mission. Please

New Opportunities for Advancing Pain Science

https://www.niams.nih.gov/about/about-the-director/letter/new-opportunities-for-advancing-pain-science

Dear Colleagues, From the Hippocratic corpus, the author writes, “I consider the responsibility of medicine to be to entirely relieve the suffering of the sick and to blunt the extremities of disease” (The Art 3.4-7)1. Note that despite the acknowledgment that disease may only be blunted, in promoting health it is our duty to relieve suffering wherever possible.

Typically materials from NIAMS that are more than 5 years old will be archived.